#New York #Rosen Law Firm #TNDM #Tandem Diabetes

Investor Alert: Rosen Law Firm Investigates Tandem Diabetes Care Class Action Claims

Rosen Law Firm, a well-known global law firm specializing in investor rights, has announced an ongoing investigation related to potential securities claims from shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM). This investigation is centered around allegations that the company possibly provided misleading business information that affected its stock value and investor confidence.

What You Need to Know

On August 7, 2025, Tandem Diabetes released a press statement addressing a voluntary medical device correction for specific models of its tslim X2 insulin pumps. According to the press release, the correction was made to fix a potential issue related to the speaker that could cause interruptions in insulin delivery. The news led to a drastic decline in Tandem Diabetes' stock, plummeting by nearly 20% the same day.

Investors who have purchased Tandem Diabetes securities may qualify for compensation through a contingency fee arrangement, meaning they do not have to pay any upfront costs. This opportunity is particularly relevant for investors who suffered losses due to the stock's sudden drop.

Steps to Take

If you are a shareholder of Tandem Diabetes and believe that you may qualify for compensation, Rosen Law Firm encourages you to take action. Potential class action participants are invited to visit Rosen Law Firm's website here or contact Phillip Kim, Esq., toll-free at 866-767-3653, or via email at [email protected]. The law firm is prepared to handle this class action lawsuit aimed at recovering investor losses.

Why Rosen Law Firm?

Selecting the right attorney is critical, particularly in class action lawsuits. Rosen Law Firm has built a solid reputation for successful outcomes and specializes exclusively in securities class actions and shareholder derivative lawsuits. Notably, the firm achieved its largest-ever securities class action settlement against a Chinese company and has consistently ranked among the top law firms for securities class action settlements, reclaiming substantial funds for investors. For example, in 2019 alone, the firm secured over $438 million for investors, showcasing its capability and commitment to investor rights.

Furthermore, Laurence Rosen, the founding partner of the firm, has been recognized as a prominent figure in plaintiff's litigation, earning the title of